Basic fibroblast growth factor (bFGF) is a potent angiogenesis factor and mediator of vascular cell function. A unique property of bFGF is that multiple forms are translated from a single mRNA via the use of separate initiation codons. These bFGF forms have distinct subcellular distributions. The smallest (18 kD) form is predominantly cytosolic; the high molecular weight (HMW) forms show a strong nuclear localization. In addition these forms induce different phenotypes. NIH 3T3 cells producing 18 kD bFGF display the properties of transformed cells, i.e. increased motility, increased growth, decreased bFGF receptor number, and increased surface beta1 integrins. Cells producing high levels of HMW bFGF also grow to high saturation densities, like 18 kD bFGF transformed cells, but show no increase in motility or beta1 surface integrins and no receptor down-regulation. In addition, HMW bFGF transformants grow in 1% serum, whereas 18 kDa bFGF transformants do not. Properties associated with 18 kD bFGF transformants are reverted by coexpression of a dominant negative FGF receptor, but those of HMW bFGF transformants are not. Curiously, cells expressing only moderate levels of HWM bFGF are growth inhibited. These results suggest that HMW bFGF utilizes a different mechanism for transformation than 18 kD bFGF, a mechanism that separates growth from certain other membrane events, and that this mechanism is, perhaps, related to its unique subcellular localization. In this grant we propose to test this hypothesis. First, the process of nuclear localization will be analyzed by examining the metabolic requirements, such as temperature and time dependence, saturability, reversibility, and pathway for nuclear import in in vitro and in vivo systems. The structural requirements for nuclear localization will be dissected using mutated forms of bFGF as well as peptides representing the amino terminus. Second, the mechanism of transformation by over-expression of HMW bFGF will be characterized. This will include a molecular analysis of the structural requirements for HMW bFGF-mediated transformation, characterization of proteins that associate with HMW bFGF, and characterization of two nuclear phosphotryosine-containing proteins whose abundance correlates with the HMW bFGF transformed state. Third, the mechanism for growth inhibition by moderate expression of HMW bFGF will be analyzed. This will include characterization of cells whose growth is inhibited by HMW bFGF, the analysis of the structural requirements for growth inhibition, and the development of genetic systems for the elucidation of growth control by HMW bFGF

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034282-15
Application #
2837596
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Program Officer
Mohla, Suresh
Project Start
1983-12-01
Project End
2000-06-30
Budget Start
1998-12-01
Budget End
2000-06-30
Support Year
15
Fiscal Year
1999
Total Cost
Indirect Cost
Name
New York University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Deryugina, Elena I; Zajac, Ewa; Zilberberg, Lior et al. (2018) LTBP3 promotes early metastatic events during cancer cell dissemination. Oncogene 37:1815-1829
Rifkin, Daniel B; Rifkin, William J; Zilberberg, Lior (2018) LTBPs in biology and medicine: LTBP diseases. Matrix Biol 71-72:90-99
Morkmued, Supawich; Hemmerle, Joseph; Mathieu, Eric et al. (2017) Enamel and dental anomalies in latent-transforming growth factor beta-binding protein 3 mutant mice. Eur J Oral Sci 125:8-17
Recouvreux, M Victoria; Camilletti, M Andrea; Rifkin, Daniel B et al. (2016) The pituitary TGF?1 system as a novel target for the treatment of resistant prolactinomas. J Endocrinol 228:R73-83
Robertson, Ian B; Rifkin, Daniel B (2016) Regulation of the Bioavailability of TGF-? and TGF-?-Related Proteins. Cold Spring Harb Perspect Biol 8:
Zilberberg, Lior; Phoon, Colin K L; Robertson, Ian et al. (2015) Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. Proc Natl Acad Sci U S A 112:14012-7
Robertson, Ian B; Horiguchi, Masahito; Zilberberg, Lior et al. (2015) Latent TGF-?-binding proteins. Matrix Biol 47:44-53
Horiguchi, Masahito; Todorovic, Vesna; Hadjiolova, Krassimira et al. (2015) Abrogation of both short and long forms of latent transforming growth factor-? binding protein-1 causes defective cardiovascular development and is perinatally lethal. Matrix Biol 43:61-70
Dabovic, Branka; Robertson, Ian B; Zilberberg, Lior et al. (2015) Function of latent TGF? binding protein 4 and fibulin 5 in elastogenesis and lung development. J Cell Physiol 230:226-36
Rognoni, Emanuel; Widmaier, Moritz; Jakobson, Madis et al. (2014) Kindlin-1 controls Wnt and TGF-? availability to regulate cutaneous stem cell proliferation. Nat Med 20:350-9

Showing the most recent 10 out of 121 publications